Literature DB >> 20939803

Diabetic retinopathy, superoxide damage and antioxidants.

Julia M Santos1, Ghulam Mohammad, Qing Zhong, Renu A Kowluru.   

Abstract

Retinopathy, the leading cause of acquired blindness in young adults, is one of the most feared complications of diabetes, and hyperglycemia is considered as the major trigger for its development. The microvasculature of the retina is constantly bombarded by high glucose, and this insult results in many metabolic, structural and functional changes. Retinal mitochondria become dysfunctional, its DNA is damaged and proteins encoded by its DNA are decreased. The electron transport chain system becomes compromised, further producing superoxide and providing no relief to the retina from a continuous cycle of damage. Although the retina attempts to initiate repair mechanisms by inducing gene expressions of the repair enzymes, their mitochondrial accumulation remains deficient. Understanding the molecular mechanism of mitochondrial damage should help identify therapies to treat/retard this sight threatening complication of diabetes. Our hope is that if the retinal mitochondria are maintained healthy with adjunct therapies, the development and progression of diabetic retinopathy can be inhibited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20939803      PMCID: PMC3214730          DOI: 10.2174/138920111794480507

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  123 in total

1.  Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes.

Authors:  Renu A Kowluru; Qing Zhong; Mamta Kanwar
Journal:  Exp Eye Res       Date:  2010-02-17       Impact factor: 3.467

Review 2.  Mitochondria: a target for cancer therapy.

Authors:  Jeffrey S Armstrong
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

Review 3.  Nitric oxide and peroxynitrite interactions with mitochondria.

Authors:  Rafael Radi; Adriana Cassina; Roberto Hodara
Journal:  Biol Chem       Date:  2002 Mar-Apr       Impact factor: 3.915

4.  Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes.

Authors:  K Naruse; J Nakamura; Y Hamada; M Nakayama; S Chaya; T Komori; K Kato; Y Kasuya; K Miwa; N Hotta
Journal:  Exp Eye Res       Date:  2000-09       Impact factor: 3.467

5.  Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.

Authors:  Elena Berrone; Elena Beltramo; Carmela Solimine; Alessandro Ubertalli Ape; Massimo Porta
Journal:  J Biol Chem       Date:  2006-02-01       Impact factor: 5.157

6.  The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.

Authors:  Natalie O Karpinich; Marco Tafani; Ronald J Rothman; Matteo A Russo; John L Farber
Journal:  J Biol Chem       Date:  2002-02-25       Impact factor: 5.157

7.  Effect of long-term administration of alpha-lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats.

Authors:  Renu A Kowluru; Sarah Odenbach
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 8.  The human mitochondrial replication fork in health and disease.

Authors:  Sjoerd Wanrooij; Maria Falkenberg
Journal:  Biochim Biophys Acta       Date:  2010-04-22

9.  Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin.

Authors:  A J Barber; E Lieth; S A Khin; D A Antonetti; A G Buchanan; T W Gardner
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

10.  The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes.

Authors:  Kazuma Miwa; Jiro Nakamura; Yoji Hamada; Keiko Naruse; Eitaro Nakashima; Koichi Kato; Yasuhide Kasuya; Yutaka Yasuda; Hideki Kamiya; Nigishi Hotta
Journal:  Diabetes Res Clin Pract       Date:  2003-04       Impact factor: 5.602

View more
  40 in total

1.  High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes.

Authors:  Kyle Trudeau; Anthony J A Molina; Sayon Roy
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-07       Impact factor: 4.799

Review 2.  Mitochondria in the pathogenesis of diabetes: a proteomic view.

Authors:  Xiulan Chen; Shasha Wei; Fuquan Yang
Journal:  Protein Cell       Date:  2012-06-22       Impact factor: 14.870

3.  Mutual enhancement between high-mobility group box-1 and NADPH oxidase-derived reactive oxygen species mediates diabetes-induced upregulation of retinal apoptotic markers.

Authors:  Ghulam Mohammad; Kaiser Alam; Mohammad Imtiaz Nawaz; Mohammad Mairaj Siddiquei; Ahmed Mousa; Ahmed M Abu El-Asrar
Journal:  J Physiol Biochem       Date:  2015-06-04       Impact factor: 4.158

4.  Mitochondrial biogenesis and the development of diabetic retinopathy.

Authors:  Julia M Santos; Shikha Tewari; Andrew F X Goldberg; Renu A Kowluru
Journal:  Free Radic Biol Med       Date:  2011-08-25       Impact factor: 7.376

5.  8-iso-prostaglandin-F2α: a possible trigger or accelerator of diabetic retinopathy.

Authors:  Ying Zhang; Yi Du; Jian-Feng He; Kai-Jun Li
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

6.  Posttranslational modification of mitochondrial transcription factor A in impaired mitochondria biogenesis: implications in diabetic retinopathy and metabolic memory phenomenon.

Authors:  Julia M Santos; Manish Mishra; Renu A Kowluru
Journal:  Exp Eye Res       Date:  2014-03-04       Impact factor: 3.467

Review 7.  Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms.

Authors:  Robert V Intine; Michael P Sarras
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

8.  The stress response protein REDD1 promotes diabetes-induced oxidative stress in the retina by Keap1-independent Nrf2 degradation.

Authors:  William P Miller; Siddharth Sunilkumar; Joseph F Giordano; Allyson L Toro; Alistair J Barber; Michael D Dennis
Journal:  J Biol Chem       Date:  2020-04-15       Impact factor: 5.157

9.  Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.

Authors:  K Szabadfi; D Reglodi; A Szabo; B Szalontai; A Valasek; Gy Setalo; P Kiss; A Tamas; M Wilhelm; R Gabriel
Journal:  Neurotox Res       Date:  2016-01-06       Impact factor: 3.911

10.  Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.

Authors:  Julia M Santos; Shikha Tewari; Jonathan Y Lin; Renu A Kowluru
Journal:  Biochem Biophys Res Commun       Date:  2013-07-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.